Current studies areing on Nexaph small protein chains, a innovative category of compounds exhibiting remarkable potential for affecting different condition pathways. Distinct from conventional drug approaches, these peptides offer enhanced selectivity and reduced off-target reactions, making them a truly encouraging option for next-generation medic